News | November 14, 2025
Novartis opens radioligand therapy facility in Carlsbad, US
Novartis is the only pharmaceutical company with a dedicated commercial RLT portfolio
Novartis is the only pharmaceutical company with a dedicated commercial RLT portfolio
OncoMate MSI Dx Analysis System is a PCR-based assay designed to evaluate MSI status in tumor tissue
New site expands manufacturing footprint to meet future demand; ensures continued on-time delivery rate of >99.9% to patients across western US, Alaska and Hawaii
The new company aims to transform cutting-edge, highly scalable technologies into innovative drug discovery platforms
The pharma giant's 11% rise in total revenue to $43.2 billion highlights consistent execution of its growth strategy
The expanded mbDNA portfolio delivers enhanced stability, reduced immunogenicity, and broad compatibility with gene insertion and expression technologies
Relmada expects to initiate its Phase 3 program in the first half of 2026
The approved ANDA is therapeutically equivalent to the reference listed drug (RLD), Sprycel Tablets
Sumatriptan injection is indicated in adults for the acute treatment of migraine
Exemestane is a key therapeutic used in the treatment of certain types of breast cancer in postmenopausal women
Subscribe To Our Newsletter & Stay Updated
